Press Releases

MADISON, WI, NOVEMBER 5, 2019 Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which… Read More »Imbed Biosciences Extends Series A Financing to $4 Million to Commercialize Innovative Bioresorbable Bandage

MADISON, WI, SEPTEMBER 27, 2019 Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a $1.5 million two-year Small Business Innovation Research (SBIR) grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health (NIH).… Read More »Imbed Biosciences Awarded $1.5 Million NIH Grant to Fight Biofilms in Wounds

MADISON, WI, APRIL 18, 2018 Imbed Biosciences, Inc. (Imbed), a medical device company emerging as a leader in the development of advanced therapies for soft tissue repair, announced today that it has secured $2 million in a Series A Preferred Stock equity financing. The funding… Read More »Imbed Biosciences Closes $2 Million in Series A Financing to Commercialize Wound Healing Matrix

MADISON, WI, July 3, 2018 Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that the company has formally received its ISO 13485:2016 certificate. The new certificate supersedes the existing certification and confirms that the company is compliant with the… Read More »Imbed Biosciences Receives ISO 13485:2016 Certification